<DOC>
	<DOCNO>NCT00036686</DOCNO>
	<brief_summary>RATIONALE : Eating diet rich soy food may slow progression type cancer . Isoflavones compound find soy food may slow growth breast cancer cell prevent development breast cancer . PURPOSE : Randomized pilot trial study effectiveness isoflavones prevent development breast cancer woman plan undergo mastectomy lumpectomy .</brief_summary>
	<brief_title>Isoflavones Treating Women Who Have Breast Cancer Are Planning Undergo Mastectomy Lumpectomy</brief_title>
	<detailed_description>OBJECTIVES : - Determine effect soy protein isolate ( isoflavones ) modulation intermediate endpoint biomarkers ( cell proliferation , apoptosis , steroid hormone ) woman plan undergo mastectomy lumpectomy breast cancer . - Determine effect soy protein isolate serum isoflavone level patient . - Correlate change serum isoflavones change cell proliferation , apoptosis , hormonal level patient treat therapy . - Correlate change cell proliferation apoptosis hormonal marker patient treat therapy . OUTLINE : This randomize , placebo-controlled , double-blind study . Patients stratify accord phase menstrual cycle time biopsy time surgery ( follicular phase [ i.e. , first 7 day menstrual cycle ] v luteal phase [ i.e. , day 7 menstrual cycle ] ) . Patients randomize one two treatment arm . - Arm I : Patients receive oral soy protein isolate twice daily oral multivitamin daily . - Arm II : Patients receive oral placebo twice daily oral multivitamin daily . In arm , treatment continue 2-4 week depend time study entry plan surgical procedure . PROJECTED ACCRUAL : A total 106 patient ( 53 per treatment arm ) accrue study within 18 month .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Undergoing breast biopsy stage breast cancer No excisional biopsy At least one core biopsy block must contain carcinoma Definitive surgery ( mastectomy lumpectomy ) plan 24 week registration study Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age : 18 Sex : Female Menopausal status : Premenopausal Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : No know prior hepatic disease Renal : No know prior renal disease Other : Not pregnant nursing Fertile patient must use effective nonhormonal contraception No prior malignancy except nonmelanoma skin cancer No know prior thyroid disease No adherence vegan diet special dietary requirement would preclude study participation No allergy study agent No obesity ( body mass index great 32 ) PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : No concurrent birth control pills hormonal therapy No concurrent thyroid hormone replacement medication Radiotherapy : Not specify Surgery : See Disease Characteristics Other : More 30 day since prior antibiotic More 4 week since prior soy product No routine consumption great 40 mg soy/day No concurrent nutritional supplement , include modular supplement isoflavones</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
	<keyword>stage IIIC breast cancer</keyword>
	<keyword>recurrent breast cancer</keyword>
	<keyword>stage IV breast cancer</keyword>
</DOC>